Intravitreal anti-vascular endothelial growth factor (VEGF) drugs have revolutionized the
treatment of neovascular age-related macular degeneration (NVAMD). However, many …

Collectively, angiogenic ocular conditions represent the leading cause of irreversible vision
loss in developed countries. In the US, for example, retinopathy of prematurity, diabetic …

Age-related macular degeneration (AMD) is a leading cause of irreversible blindness in the
world. Although the etiology and pathogenesis of AMD remain largely unclear, a complex …

The central retina mediates high acuity vision, and its progressive dysfunction due to
macular degeneration is the leading cause of visual disability among adults in industrialized …

Purpose: To evaluate the efficacy and safety of triple therapy with verteporfin photodynamic
therapy (PDT), dexamethasone, and bevacizumab in choroidal neovascularization (CNV) …

Age-related macular degeneration (AMD) represents a leading cause of blindness
worldwide. While the clinical and histopathological aspects of AMD are well characterized …

purpose. To investigate the possible protective effect of the dietary antioxidant quercetin on
retinal pigment epithelial (RPE) cell dysfunction and cellular senescence occurring in age …

Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly.
The cause of AMD is complex and many risk factors have been implicated including age …

Autoantibody production is associated with a variety of ocular disorders, including
autoimmune retinopathy (AIR) and age-related macular degeneration (AMD). A breakdown …

purpose. To investigate polymorphisms in a candidate gene of interleukin (IL) in unrelated
Taiwan Chinese patients with late age-related macular degeneration (AMD) and control …